Saiama Waqar

2022

Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors (Investigational New Drugs, (2022), 40, 3, (596-605), 10.1007/s10637-022-01216-8)

Waqar, S. N., Robinson, C., Olszanski, A. J., Spira, A., Hackmaster, M., Lucas, L., Sponton, L., Jin, H., Hering, U., Cronier, D., Grinberg, M., Seithel-Keuth, A., Diaz-Padilla, I. & Berlin, J., Jun 2022, In: Investigational New Drugs. 40, 3, p. 679 1 p.

Research output: Contribution to journal › Comment/debate

Open Access

COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience

Mehta-Shah, N., Bartlett, N. L., Kahl, B., Watkins, M. P., Dubois, A., Schmelzle, G., Waqar, S., Ballman, C., Wan, F. & Farnsworth, C. W., 2022, In: Leukemia and Lymphoma. 63, 7, p. 1723-1727 5 p.

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer

Knapp, B., Mezquita, L., Devarakonda, S., Aldea, M., Waqar, S. N., Pepin, K., Ward, J. P., Botticella, A., Howarth, K., Knape, C., Morris, C., Govindan, R., Besse, B. & Morgensztern, D., Mar 28 2022, In: Frontiers in Oncology. 12, 856132.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

LCMC study investigators, Oct 2022, In: Nature medicine. 28, 10, p. 2155-2161 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

4 Scopus citations

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors

Bagegni, N. A., Park, H., Kraft, K., O-Toole, M., Gao, F., Waqar, S. N., Ratner, L., Morgensztern, D., Devarakonda, S., Amin, M., Baggstrom, M. Q., Liang, C., Selvaggi, G. & Wang-Gillam, A., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 487-497 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer

Contreras, J., Srivastava, A., Samson, P., DeWees, T., Govindan, R., Baggstrom, M. Q., Morgensztern, D., Roach, M., Badiyan, S. N., Bradley, J., Waqar, S. & Robinson, C., Jul 15 2022, In: International Journal of Radiation Oncology Biology Physics. 113, 4, p. 742-748 7 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors

Waqar, S. N., Robinson, C., Olszanski, A. J., Spira, A., Hackmaster, M., Lucas, L., Sponton, L., Jin, H., Hering, U., Cronier, D., Grinberg, M., Seithel-Keuth, A., Diaz-Padilla, I. & Berlin, J., Jun 2022, In: Investigational New Drugs. 40, 3, p. 596-605 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer

Bogart, J. A., Waqar, S. N. & Mix, M. D., Feb 20 2022, In: Journal of Clinical Oncology. 40, 6, p. 661-670 10 p.

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors

Herzog, B. H., Waqar, S. N., Devarakonda, S., Ward, J. P., Gao, F., Govindan, R. & Morgensztern, D., Nov 2022, In: Lung Cancer. 173, p. 101-106 6 p.

Research output: Contribution to journal › Article › peer-review

Trends in Stage I Lung Cancer

Singareddy, A., Flanagan, M. E., Samson, P. P., Waqar, S. N., Devarakonda, S., Ward, J., Herzog, B. H., Rohatgi, A., Robinson, C., Gao, F., Govindan, R., Puri, V. & Morgensztern, D., 2022, (Accepted/In press) In: Clinical Lung Cancer.

Research output: Contribution to journal › Article › peer-review

2021

Adjuvant Therapy with EGFR Tyrosine Kinase Inhibitors: Tempering Great Expectations with Realism

Waqar, S. N. & Govindan, R., Mar 1 2021, In: Journal of Clinical Oncology. 39, 7, p. 697-700 4 p.

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

Mansfield, A. S., Hong, D. S., Hann, C. L., Farago, A. F., Beltran, H., Waqar, S. N., Hendifar, A. E., Anthony, L. B., Taylor, M. H., Bryce, A. H., Tagawa, S. T., Lewis, K., Niu, J., Chung, C. H., Cleary, J. M., Rossi, M., Ludwig, C., Valenzuela, R., Luo, Y. & Aggarwal, R., Dec 2021, In: npj Precision Oncology. 5, 1, 74.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations

Devarakonda, S., Pellini, B., Verghese, L., Park, H., Morgensztern, D., Govindan, R., Suresh, R., Oppelt, P., Baggstrom, M. Q., Wu, N. & Waqar, S. N., Jul 2021, In: Journal of Thoracic Disease. 13, 7, p. 4054-4062 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

Waqar, S. N., Redman, M. W., Arnold, S. M., Hirsch, F. R., Mack, P. C., Schwartz, L. H., Gandara, D. R., Stinchcombe, T. E., Leighl, N. B., Ramalingam, S. S., Tanna, S. H., Raddin, R. S., Minichiello, K., Bradley, J. D., Kelly, K., Herbst, R. S. & Papadimitrakopoulou, V. A., May 2021, In: Clinical Lung Cancer. 22, 3, p. 170-177 8 p.

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors

Park, H., Williams, K., Trikalinos, N. A., Larson, S., Tan, B., Waqar, S., Suresh, R., Morgensztern, D., Van Tine, B. A., Govindan, R., Luo, J., Lockhart, A. C. & Wang-Gillam, A., Mar 2021, In: Cancer Chemotherapy and Pharmacology. 87, 3, p. 337-347 11 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Genomic Profiling of Lung Adenocarcinoma in Never-Smokers

Devarakonda, S., Li, Y., Martins Rodrigues, F., Sankararaman, S., Kadara, H., Goparaju, C., Lanc, I., Pepin, K., Waqar, S. N., Morgensztern, D., Ward, J., Masood, A., Fulton, R., Fulton, L., Gillette, M. A., Satpathy, S., Carr, S. A., Wistuba, I., Pass, H., Wilson, R. K., & 2 othersDing, L. & Govindan, R., Nov 20 2021, In: Journal of Clinical Oncology. 39, 33, p. 3747-3758 12 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Molecular profiling-based assignment of cancer therapy (NCI-MPACT): A randomized multicenter phase II trial

Chen, A. P., Kummar, S., Moore, N., Rubinstein, L. V., Zhao, Y., Williams, P. M., Palmisano, A., Sims, D., O'Sullivan Coyne, G., Rosenberger, C. L., Simpson, M., Raghav, K. P. S., Meric-Bernstam, F., Leong, S., Waqar, S., Foster, J. C., Konaté, M. M., Das, B., Karlovich, C., Lih, C. J., & 5 othersPolley, E., Simon, R., Li, M. C., Piekarz, R. & Doroshow, J. H., Jan 2021, In: JCO Precision Oncology. 5, p. 133-144 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies

Lim, K. H., Opyrchal, M., Acharya, A., Boice, N., Wu, N., Gao, F., Webster, J., Lockhart, A. C., Waqar, S. N., Govindan, R., Morgensztern, D., Picus, J., Tan, B. R., Baggstrom, M. Q., Maher, C. A. & Wang-Gillam, A., Sep 2021, In: European Journal of Cancer. 154, p. 102-110 9 p.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Small Cell Lung Cancer, Version 2.2022

Ganti, A. K. P., Loo, B. W., Bassetti, M., Blakely, C., Chiang, A., D'Amico, T. A., D'Avella, C., Dowlati, A., Downey, R. J., Edelman, M., Florsheim, C., Gold, K. A., Goldman, J. W., Grecula, J. C., Hann, C., Iams, W., Iyengar, P., Kelly, K., Khalil, M., Koczywas, M., & 14 othersMerritt, R. E., Mohindra, N., Molina, J., Moran, C., Pokharel, S., Puri, S., Qin, A., Rusthoven, C., Sands, J., Santana-Davila, R., Shafique, M., Waqar, S. N., Gregory, K. M. & Hughes, M., Dec 2021, In: JNCCN Journal of the National Comprehensive Cancer Network. 19, 12, p. 1441-1464 24 p.

Research output: Contribution to journal › Article › peer-review

Open Access

39 Scopus citations

SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)

Borghaei, H., Redman, M. W., Kelly, K., Waqar, S. N., Robert, F., Kiefer, G. J., Stella, P. J., Minichiello, K., Gandara, D. R., Herbst, R. S. & Papadimitrakopoulou, V. A., May 2021, In: Clinical Lung Cancer. 22, 3, p. 178-186 9 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

2020

Demystifying the Role of Tumor Mutational Burden for Immunotherapy Selection - Reply

Waqar, S. N. & Govindan, R., 2020, In: JAMA oncology. 6, 11, p. 1809-1810 2 p.

Research output: Contribution to journal › Letter › peer-review

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer

Hassanzadeh, C., Sita, T., Savoor, R., Samson, P. P., Bradley, J., Gentile, M., Roach, M., Mohindra, N., Waqar, S., Kruser, T. J. & Robinson, C., Nov 2020, In: Journal of Thoracic Disease. 12, 11, p. 6690-6700 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study

Domchek, S. M., Postel-Vinay, S., Im, S. A., Park, Y. H., Delord, J. P., Italiano, A., Alexandre, J., You, B., Bastian, S., Krebs, M. G., Wang, D., Waqar, S. N., Lanasa, M., Rhee, J., Gao, H., Rocher-Ros, V., Jones, E. V., Gulati, S., Coenen-Stass, A., Kozarewa, I., & 5 othersLai, Z., Angell, H. K., Opincar, L., Herbolsheimer, P. & Kaufman, B., Sep 2020, In: The Lancet Oncology. 21, 9, p. 1155-1164 10 p.

Research output: Contribution to journal › Article › peer-review

154 Scopus citations

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy

Arnold, S. M., Chansky, K., Baggstrom, M. Q., Thompson, M. A., Sanborn, R. E., Villano, J. L., Waqar, S. N., Hamm, J., Leggas, M., Willis, M., Rosales, J. & Crowley, J. J., Jul 2020, In: Clinical Lung Cancer. 21, 4, p. 357-364.e7

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

The Mystic Role of Tumor Mutational Burden in Selecting Patients with Lung Cancer for First-Line Immunotherapy

Waqar, S. N. & Govindan, R., May 2020, In: JAMA oncology. 6, 5, p. 674-675 2 p.

Research output: Contribution to journal › Comment/debate

6 Scopus citations

2019

Association between depth of response and survival in patients with advanced-stage non–small cell lung cancer treated with first-line chemotherapy

Morgensztern, D., Ko, A., O’Brien, M., Ong, T. J., Waqar, S. N., Socinski, M. A., Postmus, P. E. & Bhore, R., Jul 15 2019, In: Cancer. 125, 14, p. 2394-2399 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

4 Scopus citations

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S. N., Patel, S., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L. P., Li, M. & Lovly, C. M., Apr 2019, In: Annals of Oncology. 30, p. ii48

Research output: Contribution to journal › Article › peer-review

Open Access

Circulating tumor DNA profiling in small-cell lung cancer identifies potentially targetable alterations

Devarakonda, S., Sankararaman, S., Herzog, B. H., Gold, K. A., Waqar, S. N., Ward, J. P., Raymond, V. M., Lanman, R. B., Chaudhuri, A. A., Owonikoko, T. K., Li, B. T., Poirier, J. T., Rudin, C. M., Govindan, R. & Morgensztern, D., Oct 15 2019, In: Clinical Cancer Research. 25, 20, p. 6119-6126 8 p.

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer

Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Leal, T. A., Du, L., Hernandez, J., Huang, V., Blumenschein, G. R., Waqar, S. N., Patel, S. P., Nieva, J., Oxnard, G. R., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., & 3 othersLim, L. P., Li, M. & Lovly, C. M., Nov 2019, In: Journal of Thoracic Oncology. 14, 11, p. 1901-1911 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

90 Scopus citations

Optimizing Targeted Therapies Using Next-Generation Sequencing

Herzog, B. H. & Waqar, S. N., Jan 1 2019, Cancer Genomics for the Clinician. Springer Publishing Company, p. 127-164 38 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

Morgensztern, D., Rose, M., Waqar, S. N., Morris, J., Ma, P. C., Reid, T., Brzezniak, C. E., Zeman, K. G., Padmanabhan, A., Hirth, J. A., I. Spira, A., Trepel, J. B. & Padda, S. K., Jul 30 2019, In: British Journal of Cancer. 121, 3, p. 211-217 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

20 Scopus citations

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Edelman, M. J., Redman, M. W., Albain, K. S., McGary, E. C., Rafique, N. M., Petro, D., Waqar, S. N., Minichiello, K., Miao, J., Papadimitrakopoulou, V. A., Kelly, K., Gandara, D. R. & Herbst, R. S., Oct 2019, In: Journal of Thoracic Oncology. 14, 10, p. 1853-1859 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

42 Scopus citations

2018

A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer and Systemic Inflammation

Giaccone, G., Sanborn, R. E., Waqar, S. N., Martinez-Marti, A., Ponce, S., Zhen, H., Kennealey, G., Erickson-Viitanen, S. & Schaefer, E., Sep 2018, In: Clinical Lung Cancer. 19, 5, p. e567-e574

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Clinical utility of cell-free DNA for the detection of ALK fusions and genomic mechanisms of ALK inhibitor resistance in non–small cell lung cancer

McCoach, C. E., Blakely, C. M., Banks, K. C., Levy, B., Chue, B. M., Raymond, V. M., Le, A. T., Lee, C. E., Diaz, J., Waqar, S. N., Purcell, W. T., Aisner, D. L., Davies, K. D., Lanman, R. B., Shaw, A. T. & Doebele, R. C., Jun 15 2018, In: Clinical Cancer Research. 24, 12, p. 2758-2770 13 p.

Research output: Contribution to journal › Article › peer-review

110 Scopus citations

Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non–Small Cell Lung Cancer

Morgensztern, D., Samson, P. S., Waqar, S. N., Devarakonda, S., Robinson, C. G., Govindan, R. & Puri, V., Apr 2018, In: Journal of Thoracic Oncology. 13, 4, p. 543-549 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

Ensartinib (X-396) in ALK-positive non–small cell lung cancer: Results from a first-in-human phase I/II, multicenter study

Horn, L., Infante, J. R., Reckamp, K. L., Blumenschein, G. R., Leal, T. A., Waqar, S. N., Gitlitz, B. J., Sanborn, R. E., Whisenant, J. G., Du, L., Neal, J. W., Gockerman, J. P., Dukart, G., Harrow, K., Liang, C., Gibbons, J. J., Holzhausen, A., Lovly, C. M. & Wakelee, H. A., Jun 15 2018, In: Clinical Cancer Research. 24, 12, p. 2771-2779 9 p.

Research output: Contribution to journal › Article › peer-review

108 Scopus citations

Immunogenicity of Influenza Vaccination in Patients with Cancer

Waqar, S. N., Boehmer, L., Morgensztern, D., Wang-Gillam, A., Sorscher, S., Lawrence, S., Gao, F., Guebert, K., Williams, K. & Govindan, R., 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 248-253 6 p.

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Lorlatinib: a new-generation drug for ALK-positive NSCLC

Waqar, S. N. & Morgensztern, D., Dec 2018, In: The Lancet Oncology. 19, 12, p. 1555-1557 3 p.

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Non–small-cell Lung Cancer With Brain Metastasis at Presentation

Waqar, S. N., Samson, P. P., Robinson, C. G., Bradley, J., Devarakonda, S., Du, L., Govindan, R., Gao, F., Puri, V. & Morgensztern, D., Jul 2018, In: Clinical Lung Cancer. 19, 4, p. e373-e379

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Paraneoplastic syndromes

Morgensztern, D., Waqar, S. N. & Govindan, R., Nov 16 2018, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. Wolters Kluwer Health Pharma Solutions (Europe) Ltd, p. 1998-2007 10 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Percutaneous Image-Guided Ablation in the Treatment of Osseous Metastases from Non-small Cell Lung Cancer

Ma, Y., Wallace, A. N., Waqar, S. N., Morgensztern, D., Madaelil, T. P., Tomasian, A. & Jennings, J. W., May 1 2018, In: Cardiovascular and Interventional Radiology. 41, 5, p. 726-733 8 p.

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer

Pietanza, M. C., Waqar, S. N., Krug, L. M., Dowlati, A., Hann, C. L., Chiappori, A., Owonikoko, T. K., Woo, K. M., Cardnell, R. J., Fujimoto, J., Long, L., Diao, L., Wang, J., Bensman, Y., Hurtado, B., de Groot, P., Sulman, E. P., Wistuba, I. I., Chen, A., Fleisher, M., & 4 othersHeymach, J. V., Kris, M. G., Rudin, C. M. & Byers, L. A., Aug 10 2018, In: Journal of Clinical Oncology. 36, 23, p. 2386-2394 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

204 Scopus citations

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer

Wagner, A. H., Devarakonda, S., Skidmore, Z. L., Krysiak, K., Ramu, A., Trani, L., Kunisaki, J., Masood, A., Waqar, S. N., Spies, N. C., Morgensztern, D., Waligorski, J., Ponce, J., Fulton, R. S., Maggi, L. B., Weber, J. D., Watson, M. A., O’Conor, C. J., Ritter, J. H., Olsen, R. R., & 10 othersCheng, H., Mukhopadhyay, A., Can, I., Cessna, M. H., Oliver, T. G., Mardis, E. R., Wilson, R. K., Griffith, M., Griffith, O. L. & Govindan, R., Dec 1 2018, In: Nature communications. 9, 1, 3787.

Research output: Contribution to journal › Article › peer-review

Open Access

69 Scopus citations

The impact of smoking and tp53 mutations in lung adenocarcinoma patients with targetable mutations—the lung cancer mutation consortium (LCMC2)

Aisner, D. L., Sholl, L. M., Berry, L. D., Rossi, M. R., Chen, H., Fujimoto, J., Moreira, A. L., Ramalingam, S. S., Villaruz, L. C., Otterson, G. A., Haura, E., Politi, K., Glisson, B., Cetnar, J., Garon, E. B., Schiller, J., Waqar, S. N., Sequist, L. V., Brahmer, J., Shyr, Y., & 7 othersKugler, K., Wistuba, I. I., Johnson, B. E., Minna, J. D., Kris, M. G., Bunn, P. A. & Kwiatkowski, D. J., Mar 1 2018, In: Clinical Cancer Research. 24, 5, p. 1038-1047 10 p.

Research output: Contribution to journal › Article › peer-review

126 Scopus citations

2017

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinumrefractory small cell lung cancer patients

Byers, L. A., Horn, L., Ghandi, J., Kloecker, G., Owonikoko, T., Waqar, S. N., Krzakowski, M., Cardnell, R. J., Fujimoto, J., Taverna, P., Azab, M. & Camidge, D. R., 2017, In: Oncotarget. 8, 46, p. 81441-81454 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

Systemic Treatment of Brain Metastases

Waqar, S. N., Morgensztern, D. & Govindan, R., Feb 1 2017, In: Hematology/Oncology Clinics of North America. 31, 1, p. 157-176 20 p.

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Treatment advances in small cell lung cancer (SCLC)

Waqar, S. N. & Morgensztern, D., Dec 2017, In: Pharmacology and Therapeutics. 180, p. 16-23 8 p.

Research output: Contribution to journal › Review article › peer-review

107 Scopus citations

2016

Adjuvant chemotherapy for patients with T2N0M0 NSCLC

Morgensztern, D., Du, L., Waqar, S. N., Patel, A., Samson, P., Devarakonda, S., Gao, F., Robinson, C. G., Bradley, J., Baggstrom, M., Masood, A., Govindan, R. & Puri, V., 2016, In: Journal of Thoracic Oncology. 11, 10, p. 1729-1735 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

60 Scopus citations

A Phase i Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer

Waqar, S. N., Baggstrom, M. Q., Morgensztern, D., Williams, K., Rigden, C. & Govindan, R., Apr 1 2016, In: Chemotherapy. 61, 3, p. 144-147 4 p.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Scopus citations

Clinician perspectives on current issues in lung cancer drug development

Waqar, S. N., Bonomi, P. D., Govindan, R., Hirsch, F. R., Riely, G. J., Papadimitrakopoulou, V., Kazandjian, D., Khozin, S., Larkins, E., Dickson, D. J., Malik, S., Horn, L., Ferris, A., Shaw, A. T., Jänne, P. A., Mok, T. S. K., Herbst, R., Keegan, P., Pazdur, R. & Blumenthal, G. M., 2016, In: Journal of Thoracic Oncology. 11, 9, p. 1387-1396 10 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

5 Scopus citations

Saiama Waqar

Research output

Search results